Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 3
2004 1
2006 1
2008 6
2009 8
2010 10
2011 7
2012 15
2013 14
2014 18
2015 19
2016 24
2017 38
2018 33
2019 59
2020 32
2021 28
2022 27
2023 29
2024 20

Text availability

Article attribute

Article type

Publication date

Search Results

336 results

Results by year

Filters applied: . Clear all
Page 1
Multivalent tyrosine kinase inhibition promotes T cell recruitment to immune-desert gastric cancers by restricting epithelial-mesenchymal transition via tumour-intrinsic IFN-γ signalling.
Cao LL, Lu H, Soutto M, Bhat N, Chen Z, Peng D, Gomaa A, Wang JB, Xie JW, Li P, Zheng CH, Nomura S, Datta J, Merchant N, Chen ZB, Villarino A, Zaika A, Huang CM, El-Rifai W. Cao LL, et al. Among authors: xie jw. Gut. 2023 Nov;72(11):2038-2050. doi: 10.1136/gutjnl-2022-329134. Epub 2023 Jul 4. Gut. 2023. PMID: 37402563
Tumor Immunophenotyping-Derived Signature Identifies Prognosis and Neoadjuvant Immunotherapeutic Responsiveness in Gastric Cancer.
Wang JB, Qiu QZ, Zheng QL, Zhao YJ, Xu Y, Zhang T, Wang SH, Wang Q, Jin QW, Ye YH, Li P, Xie JW, Lin JX, Lu J, Chen QY, Cao LL, Yang YH, Zheng CH, Huang CM. Wang JB, et al. Among authors: xie jw. Adv Sci (Weinh). 2023 May;10(15):e2207417. doi: 10.1002/advs.202207417. Epub 2023 Mar 30. Adv Sci (Weinh). 2023. PMID: 36998102 Free PMC article.
Safety and Efficacy of Indocyanine Green Tracer-Guided Lymph Node Dissection During Laparoscopic Radical Gastrectomy in Patients With Gastric Cancer: A Randomized Clinical Trial.
Chen QY, Xie JW, Zhong Q, Wang JB, Lin JX, Lu J, Cao LL, Lin M, Tu RH, Huang ZN, Lin JL, Zheng HL, Li P, Zheng CH, Huang CM. Chen QY, et al. Among authors: xie jw. JAMA Surg. 2020 Apr 1;155(4):300-311. doi: 10.1001/jamasurg.2019.6033. JAMA Surg. 2020. PMID: 32101269 Clinical Trial.
Loss of ATOH1 in Pit Cell Drives Stemness and Progression of Gastric Adenocarcinoma by Activating AKT/mTOR Signaling through GAS1.
Zhong Q, Wang HG, Yang JH, Tu RH, Li AY, Zeng GR, Zheng QL, Yu Liu Z, Shang-Guan ZX, Bo Huang X, Huang Q, Li YF, Zheng HL, Lin GT, Huang ZN, Xu KX, Qiu WW, Jiang MC, Zhao YJ, Lin JX, Huang ZH, Huang JM, Li P, Xie JW, Zheng CH, Chen QY, Huang CM. Zhong Q, et al. Among authors: xie jw. Adv Sci (Weinh). 2023 Nov;10(32):e2301977. doi: 10.1002/advs.202301977. Epub 2023 Oct 12. Adv Sci (Weinh). 2023. PMID: 37824217 Free PMC article.
Optimal postoperative surveillance strategies for cancer survivors with gastric neuroendocrine carcinoma based on individual risk: a multicenter real-world cohort study.
Xu BB, He XY, Zhou YB, He QL, Tian YT, Hao HK, Qiu XT, Jiang LX, Zhao G, Li Z, Xu YC, Fu WH, Xue FQ, Li SL, Xu ZK, Zhu ZG, Li Y, Li E, Chen JP, Li HL, Cai LS, Wu D, Li P, Zheng CH, Xie JW, Lu J, Huang CM. Xu BB, et al. Among authors: xie jw. Int J Surg. 2023 Jun 1;109(6):1668-1676. doi: 10.1097/JS9.0000000000000401. Int J Surg. 2023. PMID: 37076132 Free PMC article. Clinical Trial.
Indocyanine green fluorescence imaging-guided versus conventional laparoscopic lymphadenectomy for gastric cancer: long-term outcomes of a phase 3 randomised clinical trial.
Chen QY, Zhong Q, Liu ZY, Li P, Lin GT, Zheng QL, Wang JB, Lin JX, Lu J, Cao LL, Lin M, Tu RH, Huang ZN, Zeng GR, Jiang MC, Wang HG, Huang XB, Xu KX, Li YF, Zheng CH, Xie JW, Huang CM. Chen QY, et al. Among authors: xie jw. Nat Commun. 2023 Nov 16;14(1):7413. doi: 10.1038/s41467-023-42712-6. Nat Commun. 2023. PMID: 37973806 Free PMC article. Clinical Trial.
Neoadjuvant camrelizumab and apatinib combined with chemotherapy versus chemotherapy alone for locally advanced gastric cancer: a multicenter randomized phase 2 trial.
Lin JX, Tang YH, Zheng HL, Ye K, Cai JC, Cai LS, Lin W, Xie JW, Wang JB, Lu J, Chen QY, Cao LL, Zheng CH, Li P, Huang CM. Lin JX, et al. Among authors: xie jw. Nat Commun. 2024 Jan 2;15(1):41. doi: 10.1038/s41467-023-44309-5. Nat Commun. 2024. PMID: 38167806 Free PMC article. Clinical Trial.
336 results